We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+25.67%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$8.92B
Cap. Flow
+$6.38B
Cap. Flow %
38.87%
Top 10 Hldgs %
11.97%
Holding
501
New
64
Increased
117
Reduced
241
Closed
32

Top Buys

Rank Stock Value
1
PINS icon
Pinterest
PINS
+$181M
2
CRWD icon
CrowdStrike
CRWD
+$173M
3
RNG icon
RingCentral
RNG
+$166M
4
SNPS icon
Synopsys
SNPS
+$158M
5
WCN
Waste Connections
WCN
+$152M

Sector Composition

Rank Sector Weight
1 Technology 28.21%
2 Healthcare 20.91%
3 Industrials 14.05%
4 Consumer Discretionary 13.18%
5 Financials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNSL icon
176
Kinsale Capital Group
KNSL
$8.5B
$29.2M 0.18%
145,738
+11,601
+9% +$2.54M
RSI icon
177
Rush Street Interactive
RSI
$3.08B
$29M 0.18%
+1,340,649
New +$20.1M
EG icon
178
Everest Group
EG
$14.6B
$28.7M 0.17%
122,694
+74,706
+156% +$16.5M
EXP icon
179
Eagle Materials
EXP
$5.97B
$28.5M 0.17%
281,380
-48,095
-15% -$4.47M
DHI icon
180
D.R. Horton
DHI
$39.9B
$28.5M 0.17%
413,257
-122,185
-23% -$8.91M
VZ icon
181
Verizon
VZ
$208B
$28.5M 0.17%
484,368
MCD icon
182
McDonald's
MCD
$181B
$28.3M 0.17%
131,900
RARE icon
183
Ultragenyx Pharmaceutical
RARE
$1.51B
$28M 0.17%
202,025
-17,220
-8% -$2.04M
CSCO icon
184
Cisco
CSCO
$431B
$27.4M 0.17%
612,943
+75,004
+14% +$3.08M
MDT icon
185
Medtronic
MDT
$120B
$27.4M 0.17%
234,114
PEP icon
186
PepsiCo
PEP
$188B
$27.3M 0.17%
184,051
CCL icon
187
Carnival Corporation Ltd
CCL
$32.2B
$27M 0.16%
1,245,093
-54,229
-4% -$964K
BC icon
188
Brunswick
BC
$4.82B
$26.9M 0.16%
353,422
-51,152
-13% -$3.61M
KLAC icon
189
KLA
KLAC
$242B
$26.8M 0.16%
1,034,960
-7,000
-0.7% -$163K
JBLU icon
190
JetBlue
JBLU
$1.75B
$26.8M 0.16%
1,841,947
-385,865
-17% -$5.29M
ZBRA icon
191
Zebra Technologies
ZBRA
$17.2B
$26.2M 0.16%
68,196
-2,686
-4% -$904K
ALNY icon
192
Alnylam Pharmaceuticals
ALNY
$35.6B
$26.2M 0.16%
+201,572
New +$26.9M
INSP icon
193
Inspire Medical Systems
INSP
$1.82B
$26.1M 0.16%
138,839
-61,324
-31% -$10M
THO icon
194
Thor Industries
THO
$4.01B
$26M 0.16%
279,810
-20,027
-7% -$1.88M
LSCC icon
195
Lattice Semiconductor
LSCC
$16.5B
$25.6M 0.16%
559,700
-55,844
-9% -$2.16M
P
196
Everpure Inc
P
$33.1B
$25.6M 0.16%
1,132,403
-345,846
-23% -$6.63M
CVX icon
197
Chevron
CVX
$409B
$25.5M 0.16%
302,488
+100,374
+50% +$8.13M
DFS
198
DELISTED
Discover Financial Services
DFS
$25.3M 0.15%
279,454
+231,322
+481% +$17.3M
THR
199
DELISTED
Thermon Group Holdings
THR
$25.3M 0.15%
1,616,313
SABR icon
200
Sabre
SABR
$860M
$25.1M 0.15%
+2,089,825
New +$19.3M

Similar funds

Carillon Tower Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Carillon Tower Advisers held 501 positions worth $16.4B, up 119% from $7.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Carillon Tower Advisers deployed $6.38B of net new capital in Q4 2020, opening 64 new positions and adding to 117 existing holdings. Its largest new stake was Pinterest: 3,021,131 shares worth $199M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Q2 Holdings, an estimated $278M trimmed.

  • Carillon Tower Advisers's largest Q4 2020 buy was Pinterest: 3,021,131 shares worth $199M.
  • Carillon Tower Advisers added most to CrowdStrike in Q4 2020, an estimated $173M increase.
  • Carillon Tower Advisers's biggest Q4 2020 reduction was Q2 Holdings, cutting an estimated $278M.
  • Carillon Tower Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020, selling an estimated $31.6M.
  • Carillon Tower Advisers's ten largest holdings make up 12% of its $16.4B portfolio in Q4 2020.
  • Carillon Tower Advisers opened 64 new positions and closed 32 in Q4 2020.
  • Carillon Tower Advisers's portfolio value rose 119% quarter-over-quarter to $16.4B.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.